263 related articles for article (PubMed ID: 35214796)
1. Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for Vaccines.
Ravindranath MH; Ravindranath NM; Selvan SR; Filippone EJ; Amato-Menker CJ; El Hilali F
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214796
[TBL] [Abstract][Full Text] [Related]
2. Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment.
Ravindranath MH; Ravindranath NM; Amato-Menker CJ; El Hilali F; Selvan SR; Filippone EJ; Morales-Buenrostro LE
Antibodies (Basel); 2023 Mar; 12(2):. PubMed ID: 37092447
[TBL] [Abstract][Full Text] [Related]
3. Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
Ravindranath MH; Ravindranath NM; Selvan SR; Hilali FE; Amato-Menker CJ; Filippone EJ
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627243
[TBL] [Abstract][Full Text] [Related]
4. Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.
Ravindranath MH; El Hilali F; Amato-Menker CJ; El Hilali H; Selvan SR; Filippone EJ
Antibodies (Basel); 2022 Sep; 11(3):. PubMed ID: 36134954
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to β2-microglobulin-free monomer.
Sasaki T; Ravindranath MH; Terasaki PI; Freitas MC; Kawakita S; Jucaud V
Int J Cancer; 2014 Apr; 134(7):1558-70. PubMed ID: 24105714
[TBL] [Abstract][Full Text] [Related]
6. Monitoring native HLA-I trimer specific antibodies in Luminex multiplex single antigen bead assay: Evaluation of beadsets from different manufacturers.
Ravindranath MH; Jucaud V; Ferrone S
J Immunol Methods; 2017 Nov; 450():73-80. PubMed ID: 28782523
[TBL] [Abstract][Full Text] [Related]
7. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.
Khare SD; Hansen J; Luthra HS; David CS
J Clin Invest; 1996 Dec; 98(12):2746-55. PubMed ID: 8981920
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to HLA-E bind epitopes carried by unfolded β2 m-free heavy chains.
Tremante E; Lo Monaco E; Ingegnere T; Sampaoli C; Fraioli R; Giacomini P
Eur J Immunol; 2015 Aug; 45(8):2356-64. PubMed ID: 25982269
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA class I molecules assembled with structural variants of human beta2-microglobulin.
Trymbulak WP; Zeff RA
Immunogenetics; 1997; 46(5):418-26. PubMed ID: 9271632
[TBL] [Abstract][Full Text] [Related]
10. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.
Desai SA; Wang X; Noronha EJ; Zhou Q; Rebmann V; Grosse-Wilde H; Moy FJ; Powers R; Ferrone S
J Immunol; 2000 Sep; 165(6):3275-83. PubMed ID: 10975844
[TBL] [Abstract][Full Text] [Related]
11. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells.
Madrigal JA; Belich MP; Benjamin RJ; Little AM; Hildebrand WH; Mann DL; Parham P
J Exp Med; 1991 Nov; 174(5):1085-95. PubMed ID: 1940790
[TBL] [Abstract][Full Text] [Related]
12. Impaired assembly results in the accumulation of multiple HLA-C heavy chain folding intermediates.
Sibilio L; Martayan A; Setini A; Fraioli R; Fruci D; Shabanowitz J; Hunt DF; Giacomini P
J Immunol; 2005 Nov; 175(10):6651-8. PubMed ID: 16272320
[TBL] [Abstract][Full Text] [Related]
13. Expression of distinct conformations of free HLA-Cw4 heavy chains in transfected neuroblastoma cells.
Marozzi A; Meneveri R; De Santis C; Robbioni P; Molteni E; Beretta A; Siccardi AG; Ginelli E
Immunogenetics; 1996; 43(5):289-95. PubMed ID: 9110932
[TBL] [Abstract][Full Text] [Related]
14. NMR spectroscopy reveals unexpected structural variation at the protein-protein interface in MHC class I molecules.
Beerbaum M; Ballaschk M; Erdmann N; Schnick C; Diehl A; Uchanska-Ziegler B; Ziegler A; Schmieder P
J Biomol NMR; 2013 Oct; 57(2):167-78. PubMed ID: 24006098
[TBL] [Abstract][Full Text] [Related]
15. HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsiveness.
Giacomini P; Beretta A; Nicotra MR; Ciccarelli G; Martayan A; Cerboni C; Lopalco L; Bini D; Delfino L; Ferrara GB; Siccardi AG; Natali PG
Tissue Antigens; 1997 Dec; 50(6):555-66. PubMed ID: 9458108
[TBL] [Abstract][Full Text] [Related]
16. Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis.
Vázquez MN; López de Castro JA
Arthritis Rheum; 2005 Oct; 52(10):3290-9. PubMed ID: 16200602
[TBL] [Abstract][Full Text] [Related]
17. Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase.
Demaria S; DeVito-Haynes LD; Salter RD; Burlingham WJ; Bushkin Y
Hum Immunol; 1999 Dec; 60(12):1216-26. PubMed ID: 10626735
[TBL] [Abstract][Full Text] [Related]
18. Enhancing Natural Killer and CD8
Ravindranath MH; Filippone EJ; Devarajan A; Asgharzadeh S
Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):38-59. PubMed ID: 31009335
[TBL] [Abstract][Full Text] [Related]
19. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
[TBL] [Abstract][Full Text] [Related]
20. Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients.
Ravindranath MH; Ravindranath NM; El Hilali F; Selvan SR; Filippone EJ
Antibodies (Basel); 2022 Mar; 11(1):. PubMed ID: 35323192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
